Alpine Associates Management’s BioTelemetry, Inc. BEAT Stock Holding History

Alpine Associates Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,237,203	Closed	-$89.2M	–	72
2020 Q4	$89.2M	Buy	+1,237,203	New	+$64.8M	3.65%	11

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Alpine Associates Management's BEAT Position: Q1 2021 in Review

Alpine Associates Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 1,237,203 shares — an estimated $89.2M sold.

Alpine Associates Management first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $89.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Alpine Associates Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Alpine Associates Management sold 1,237,203 BioTelemetry, Inc. shares in Q1 2021, an estimated $89.2M.
Alpine Associates Management first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Alpine Associates Management's BioTelemetry, Inc. position peaked at $89.2M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Alpine Associates Management's 13F filing for Q1 2021, filed 11 May 2021.